CHRI Seminar Series - CAR-T Cell Therapy for Pediatric Oncology: The Peril and the Promise

Monday, March 5, 2018

12:00 pm

Li Ka Shing Learning Center - Room #102, 291 Campus Drive, Stanford, CA 94305

Sponsored by:
Child Health Research Institute

About the Seminar

The Stanford Child Health Research Institute will present its first seminar on CAR-T Cell Therapy for Pediatric Oncology: The Peril and the Promise. Over lunch, learn more from our speakers with opening by CHRI executive director, Dr. Mary Leonard, who will kick-off the Institute's educational series on the latest developments in maternal child heath. Dr. Crystal Mackall will then highlight research in CAR-T cell therapies for pediatric oncology followed by a presentation from Mr. Christopher Mount.

Mary Leonard, MD, MSCE - The Arline and Pete Harman Professor and Chair in the Department of Pediatrics at Stanford School of Medicine; Physician-in-Chief at the Lucile Packard Children's Hospital; Executive Director of the Stanford Child Health Institute

Crystal Mackall, MD - Endowed Professor of Pediatrics and Medicine, Stanford University; Director of the Parker Institute for Cancer Immunotherapy at Stanford

Christopher Mount - MD/PHD Graduate Student, Member of the Neuroscience Graduate Program in Dr. Michelle Monje’s Laboratory, Stanford

About the Series

The CHRI Education Seminars highlight compelling clinical topics, innovative research, and the latest developments in maternal child health, and serves as a forum for engaging in conversations with other researchers and scientists across the community. Students, faculty, and postdoctoral researchers are encouraged to attend the seminars. Seats are limited and reservations are required. Lunch will be provided. Check out more CHRI Education Seminars.

Monday, March 5, 2018
12:00 pm – 1:00 pm
Li Ka Shing Learning Center - Room #102, 291 Campus Drive, Stanford, CA 94305

Lunch provided. You must register at


Lecture / Reading 

Faculty/Staff, Students, Members
More info:
Visit this website